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Nanoparticle Treatment to Counter Reactive Oxygen Species after
Traumatic Brain Injury
Brandon McDonald & Dr. Forrest Kievit
Department of Biological Systems Engineering
University of Nebraska Lincoln

Nanoparticle Therapy

Superoxide Dismutase Activity Assay

Secondary damage is caused by an increase
in oxidative stress, which forces a
biochemical imbalance in the brain. The
spread of reactive oxygen species (ROS) is
one of the main components for the longterm development in TBI. We used the
NPs of Yoo et al. 2017, shown in Figure 1,
in efforts to bind and inactivate ROS,
reducing the spread of damage.3

Superoxide Dismutase (SOD) is an antioxidant enzyme involved in the body’s
oxidative equilibrium system, which converts ROS into oxygen and hydrogen
peroxide, as shown in Figure 2.4 Xanthine Oxidase (XO) is an enzyme that
catalyzes the reaction of hypoxanthine into uric acid and ROS.5 Hypoxanthine
is a purine derivative catabolized from nucleic acids or ATP. In this assay,
Tetrazolium Salt WST-1 is reduced into a water soluble dye upon the reaction
with ROS. SOD will reduce levels of ROS, which are generated by XO, by
converting them into oxygen and hydrogen peroxide. The higher the levels of
SOD activity, the less dye will be produced. In order to counter oxidative stress,
brain tissue will increase the expression of SOD. Our hypothesis states that NP
treatments will reduce oxidative stress in the brain, reducing SOD expression.

Background
Traumatic Brain Injury (TBI) is defined as
damage to the brain, resulting from an
external mechanical force.1 TBI is currently
the leading cause of death and disability in
children and young adults, with 1.7 million
reported cases annually in the United States
alone.2 The initial trauma is followed by
secondary corrosive damage to the brain.
There are currently no treatments to protect
the brain from this deterioration. The aim for
this project was to study the effects of
nanoparticle (NP) treatments on reducing
this secondary damage using a mouse model
of TBI.
Figure 1:
Thioether core NPs
utilized in these
experiments.

Controlled Cortical Impact
Controlled Cortical Impact (CCI) is a
commonly utilized method for modeling a
TBI. The impactor is placed over the left
frontoparietal cortex of the mouse’s brain.
Impact parameters include 4 m/s velocity to
a depth of 2.5 mm with a 80 ms dwell time
followed by NP tail vein injections.
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Figure 3: CCI-L
SOD Activity normalized to protein concentration of brain samples,
after 24 hr. following CCI experiments. Samples include left and
right (L/R) sides of the brain for mice with (NP) and without (CCI)
NP treatment, in addition to a sample control (C) that did not
receive damage.

Analysis was conducted using the data
collected from the SOD assay experiments,
after 24 hours following CCI experiments.
From the results provided in Figure 3, brain
samples from the left and right sides of the
brain following CCI experiments contained
higher levels of SOD activity than the
control. Additionally, brain samples from
the right side of the brain, which did not
receive NP treatment had higher levels of
SOD Activity, than samples that received
treatment.
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Figure 2:
Diagram illustrating the
conversion of ROS into Oxygen
and Hydrogen Peroxide by the
enzyme, SOD.

Discussion
Based on the data collected from
these SOD assay experiments,
evidence showed that NPs
reduced the spread of oxidative
stress to the contralateral brain
suggested by the reduction of
SOD activity in comparison to
the injured animals that did not
receive NPs. Additional studies
are needed in order to confirm
the benefits of NPs in reducing
the spread of ROS, however, this
project offers promise for the
promotion of future research.
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